false 0001479419 0001479419 2024-09-23 2024-09-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 23, 2024

 

 

 

KALA BIO, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware 001-38150 27-0604595
(State or Other Jurisdiction of
Incorporation)		 (Commission File Number) (IRS Employer Identification No.)

 

1167 Massachusetts Avenue

Arlington, MA 02476

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (781) 996-5252

 

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol(s) Name of each exchange on which
registered
Common Stock, $0.001 par value per share KALA The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 23, 2024, Mark S. Blumenkranz, M.D. notified KALA BIO, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company, effective immediately. With the resignation, Dr. Blumenkranz also resigned as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee. Dr. Blumenkranz informed the Company that his resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  KALA BIO, INC.
     
Date: September 25, 2024 By: /s/ Mary Reumuth
    Mary Reumuth
    Chief Financial Officer and Corporate Secretary

 

 

 

v3.24.3
Cover
Sep. 23, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 23, 2024
Entity File Number 001-38150
Entity Registrant Name KALA BIO, Inc.
Entity Central Index Key 0001479419
Entity Tax Identification Number 27-0604595
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1167 Massachusetts Avenue
Entity Address, City or Town Arlington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02476
City Area Code 781
Local Phone Number 996-5252
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol KALA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more KALA BIO Charts.
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more KALA BIO Charts.